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Cocultures of ﬁbroblasts and keratinocytes, physically separated by a membrane, were carried out for 48 h, and
large-scale gene expression in the ﬁbroblasts was analyzed by Affymetrix microarrays of expressed mRNAs. Two
independent experiments were performed with cells from different individuals. A total of 243 genes were
upregulated twofold or more and 100 genes were negatively regulated (reduction by half or more) in both
experiments. A total of 69 of these 343 genes coded for growth factors, cytokines, chemokines, or their receptors;
extracellular matrix molecules or enzymes involved in their synthesis; adhesion receptors; proteinases/proteinase
inhibitors or their receptors; cell cycle regulators; apoptosis-regulating factors; prostaglandin-related factors; or
growth-factor-binding proteins. Most of the remaining genes coded for proteins involved in signal transduction or
general metabolism. Sixteen genes selected from these groups were further analyzed by northern blot analysis to
conﬁrm the array data. Finally, experiments with interleukin-1a (IL-1a)-blocking antibodies or IL-1 receptor
antagonists demonstrate that IL-1a is one important factor involved in keratinocyte-mediated regulation of gene
expression in ﬁbroblasts. Taken together, the results suggest that keratinocytes regulate ﬁbroblast gene
expression with implications for the wound healing process during reepithelialization.
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It is well established that epithelial–mesenchymal interac-
tions are important for development of tissue integrity
during embryogenesis (Mackenzie, 1994). It has also
become clear that such interactions also are important for
various processes in the adult organism, such as during
mammary gland development (Howlett and Bissell, 1993)
and tumor progression (Ronnov-Jessen et al, 1996). An
important aspect of wound healing is the process of
reepithelialization. During this process, keratinocytes are
dependent on communication with dermal fibroblasts for
the reestablishment of a functional epidermis (Smola et al,
1998; el-Ghalbzouri et al, 2002). The nature of this
communication most probably involves secreted cytokines
and other factors establishing paracrine ‘‘loops’’ between
the two cell types. Interleukin (IL)-1 and keratinocyte growth
factor have been implicated in this process (Maas-Szabow-
ski et al, 1999). It is not known whether communication
between fibroblasts and keratinocytes also regulate other
processes involved in different stages of wound healing.
Nevertheless, we previously demonstrated the ability of
keratinocytes to downregulate connective tissue growth
factor in fibroblasts by an IL-1-dependent mechanism in
absence of physical contact between the two cell types
(Nowinski et al, 2002). This might reflect an ability of newly
formed epithelium to suppress certain aspects of fibroblast
activities, such as deposition of extracellular matrix mole-
cules. In this study we aimed at understanding, on a more
general basis, how keratinocytes may affect the activity of
fibroblasts during the process of reepithelialization. For this
purpose, we used a method in which subconfluent
keratinocytes were cocultured in vitro with fibroblasts for
48 h, and large-scale gene expression in fibroblasts was
analyzed by a microarray approach.
Results
Microarray analysis of ﬁbroblast gene expression In a
first experiment from one pair of individuals, 869 genes
were upregulated twofold or more, and 454 genes were
downregulated by half or more in fibroblasts after a
coculture period of 48 h. In a second experiment, using
cells from other individuals, 473 genes were upregulated
Abbreviations: HAS, hyaluronan synthase; IGFBP, insulin-
like growth factor-binding protein; IL, interleukin; MMP,
matrix metalloproteinase; PAI, plasminogen activator inhi-
bitor; PGE, prostaglandin E; VEGF, vascular endothelial
growth factor.
1Tables 1, 2 and 5 can be found online at http://www.
blackwellpublishing.com/products/journals/suppmat/jid/
jid22112/jid22112sm.htm
Copyright r 2003 by The Society for Investigative Dermatology, Inc.
216
and 109 genes were downregulated by the same criteria.
When comparing the two arrays, 243 genes were upregu-
lated twofold or more in both sets of experiments (Table I),
and the corresponding number for negatively regulated
genes was 100 (Table II). Together, these 343 genes (either
positively or negatively regulated) could be classified into 10
groups based on their function as follows: (1) growth factors
and cytokines; (2) growth factor/cytokine receptors; (3)
extracellular matrix molecules or enzymes involved in their
synthesis; (4) adhesion receptors; (5) proteinases/protei-
nase inhibitors or their receptors; (6) cell cycle regulators; (7)
apoptosis-regulating factors; (8) prostaglandins and related
factors; (9) growth factor-binding proteins; and (10) other
genes. The last group consisted of genes implicated in, for
example, signal transduction or general metabolism. Genes
whose expression did not allow for calculation of relative
increase or decrease owing to the fact that signal intensity
did not exceed the background level in control cultures for
stimulated genes, or in coculture with keratinocytes for
down-regulated genes, are indicated in the tables.
Analysis of keratinocyte-regulated ﬁbroblast gene
expression by northern blotting Northern blot (mRNA)
analysis was used to confirm regulation of 16 selected
genes based on the microarray results and availability of
cDNAs for the different genes. Fibroblast mRNA levels for
these genes, representing different functional groups, were
determined after 24 and 48 h of coculture with keratinocytes
(Fig 1, Table III). These experiments were performed with
cells from other individuals than those used for the arrays.
Following mRNA analysis, the 16 genes examined could be
divided into two groups: (1) upregulated genes (13 genes—
cyclin B1, prolyl 4-hydroxylase, GRO-a, MCP-2, MMP-1,
MMP-3, PGE-synthase, HAS-2, IL-8, lysyl hydroxylase 2,
fibromodulin, G-CSF, PAI-1, and VEGF-A) (Fig 1A) and (2)
downregulated genes (3 genes—IGFBP-3, tetranectin, and
WISP-2) (Fig 1B). Most genes were regulated according to
the arrays both at 24 and at 48 h of coculture (Fig 1). Taken
together, we were able to qualitatively confirm the micro-
array results of 16 genes tested in a third set of cells from
individuals distinct from those used for the arrays.
Keratinocyte-derived IL-1a is mediating regulation of
gene expression in ﬁbroblasts We previously showed
that keratinocytes suppress expression of connective tissue
growth factor in fibroblasts by an IL-1a-dependent mechan-
ism in an identical coculture model as described here
(Nowinski et al, 2002). We therefore hypothesized that IL-1a
is involved in keratinocyte-mediated regulation of some of
the fibroblast genes identified in this study as well. To
investigate this possibility, we added IL-1a antibodies or IL-
1 receptor antagonists to the cell culture medium upon
initiation of the cocultures, to block IL-1a function. Levels of
mRNA for the 16 genes that confirmed the array results
were measured by northern blot analysis after a coculture
period of 48 h. Interestingly, expression of all 16 genes in
coculture, whether up- or downregulated, were shown to be
fully or partly reversed by the addition of blocking IL-1a
antibodies or IL-1 receptor antagonists (Fig 2; Tables IV, V).
Hence, blocking IL-1 function in cocultures reversed, at
least partly, keratinocyte-regulated expression of 16 genes
tested.
Discussion
We demonstrate that keratinocytes regulate the expression
of 343 fibroblast genes in an in vitro coculture model. A
majority of these genes were stimulated, supporting the
view that keratinocytes act to stimulate fibroblast activity
during the reepithelialization process. In addition, we
identified IL-1a as an important potential keratinocyte-
derived factor that regulates fibroblast gene expression
during this process.
Wound healing is classically divided in three phases:
inflammation, proliferation, and tissue remodeling. Fibro-
blasts play an important role in the rebuilding of tissue
integrity and are recruited to the wound area at the end of
the inflammatory phase. Fibroblasts appear in the wound
area approximately at the same time as keratinocytes
during the process of reepithelialization. Accordingly, it is
possible that keratinocytes influence fibroblast activity
during this period in the process of wound healing, a view
that is supported by our results. More specifically, the
Figure1
Northern blot analysis of keratinocyte-regulated genes in fibro-
blasts. Fibroblasts were cocultured with keratinocytes for 24 or 48 h,
and mRNA expression for 16 genes was analyzed. (A) Expression of 13
genes upregulated in accordance with the arrays. (B) Expression of 3
genes downregulated in accordance with the arrays. P4-H, prolyl-4
hydroxylase; LH-2, lysyl hydroxylase 2; MMP-1, matrix metalloprotei-
nase 1; VEGF-A, vascular endothelial growth factor A; MMP-3, matrix
metalloproteinase 3; PGE-synthase, prostaglandin E-synthase; HAS-2,
hyaluronan synthase 2; IL-8, interleukin-8; GROa, GRO1 oncogene;
MCP-2, monocyte chemotactic protein 2; PAI-1, plasminogen activator
inhibitor 1; IGFBP-3, insulin-like growth factor binding protein 3; WISP-
2, WNT1-inducible signaling pathway protein 2.
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keratinocyte-mediated changes in fibroblast gene expres-
sion identified in this study potentially play a role in
leukocyte attraction/activation, fibroblast and keratinocyte
proliferation, angiogenesis, and extracellular matrix mod-
ulation. Individual genes or family of genes that were
stimulated and supporting a role in leukocyte attraction
and activation include IL-6, -8, -11, and -15 and chemo-
kines (e.g., GRO-1, -2, and -3 MCP-1, -2, and -3). Genes
involved in proliferation of fibroblast and keratinocytes are,
for example, fibroblast growth factors, various cyclins, and
epidermal growth factor. Proangiogenic genes include
endothelial cell growth factor 1, VEGF-A, GRO-1, and
IGF-I. Genes involved in extracellular matrix modulation
include fibromodulin, HAS-2, MMP-1 and -3, proteinase
inhibitors (e.g., PAI-1 and -2 CAP-2), and urokinase
receptor. The genes for prolyl 4-hydroxylase and lysyl-
hydroxylase, enzymes important for the synthesis of
collagen, were also stimulated by keratinocyte-derived
factors. This was not correlated by any significant increase
in expression of the genes coding for the structural
collagens. In contrast, mRNAs encoding type I collagen,
the most abundant structural collagen, was decreased by
20% in this study (not shown). In addition to these groups of
genes, gene expression of proteins involved in signal
transduction and general metabolism was also significantly
affected (Tables I, II). The role of these proteins for the
activity of fibroblasts is difficult to dissect but they are likely
important for the changes seen in the other groups of
genes, which have more obvious roles in the context of
tissue regeneration. The genes that were not regulated
commonly in the two experiments (not shown) most likely
reflect the fact that cells from different individuals were
utilized. The Northern blot confirmation of 16 genes in a
third population of cells support that commonly regulated
genes, as given by the two sets of arrays, indeed reflect
universal changes in fibroblasts. Moreover, regulation of the
16 genes was observed at both 24 and 48 h of coculturing,
according to the northern blot analysis (Fig 1).
We previously demonstrated that expression of con-
nective tissue growth factor by fibroblasts was suppressed
in coculture with keratinocytes by keratinocyte-derived
IL-1a (Nowinski et al, 2002). According to this we found
1.8-fold downregulation of connective tissue growth factor
mRNA in the two arrays of this report (data not shown). This
prompted us to analyze to what extent expression of the 16
keratinocyte-regulated genes confirmed by northern blot in
the third set of cells was also dependent on IL-1a. We found
that regulation of 16 of these genes in cocultures was partly
or fully reversed by adding blocking anti-IL-1a antibodies or
IL-1 receptor antagonists (Fig 2, Table V). For the majority of
these genes, regulation by IL-1 has previously been
demonstrated (IL-8, Maas-Szabowski and Fusenig, 1996;
GRO-1, Bedard and Golds, 1993; HAS-2, Nishida et al,
2000; MMP-1, Lyons et al, 1993; MMP-3, Sodin-Semrl et al,
2000; PGE-synthase, Stichtenoth et al, 2001; MCP-2, Van
Coillie et al, 1999; and PAI-1, Michel and Quertermous,
1989; VEGF, Ben-Avenue et al, 1995). Nevertheless, for
some of the genes IL-1 dependence has, according to our
knowledge, not been shown before (fibromodulin, tetra-
nectin, prolyl 4-hydroxylase, WISP-2, and lysyl hydroxylase
2). The fact that some of the 16 genes responded only
partially to the IL-1-blocking strategies suggests the
existence of other factors that act in collaboration with
IL-1 to regulate fibroblast gene expression (Fig 2).
Earlier studies using organotypic tissue culture models
have shown that keratinocytes secrete IL-1 during reepithe-
lialization (Nowinski et al, 2002; Hauser et al, 1986; Goretsky
et al, 1996). Fibroblasts respond to this by secreting, for
example, keratinocyte growth factor, which further stimu-
lates keratinocyte proliferation and epidermal tissue regen-
eration (Maas-Szabowski et al, 1999). In our cocultures, the
level of keratinocyte growth factor gene expression in
fibroblasts was increased 1.8- and 1.9-fold according to the
arrays (not shown) thus supporting these findings. Another
possible ‘‘loop,’’ which may exist according to our data, is
keratinocyte-mediated stimulation of IGF-I in fibroblasts
(Table I) and subsequent IGF-I-mediated keratinocyte
growth. This is a possibility that is supported by earlier
studies (Neely et al, 1991; Wraight et al, 1994). Interestingly,
keratinocytes suppressed IGFBP-3 expression (Table II,
Fig 1B), which could further enhance the activity of IGF-I. It
is possible that similar intercellular communications exist
also in vivo and constitute an important aspect of rebuilding
of tissue integrity. Further studies will be needed to translate
our in vitro data into the possible in vivo relevance.
Materials and Methods
Antibodies and reagents Neutralizing IL-1a antibodies and IL-1
receptor antagonists were obtained from R & D Systems
(Minneapolis, MN). Patient consent was obtained.
Table III. Relative mRNA signal levels by northern blottinga
F 24 h K 24 h F 48 h K 48 h
Upregulated genes
Cyclin B1 1 5.39 0.99 6.33
P4-H 1 1.83 0.44 1.24
LH-2 1 1.36 1.35 1.89
Fibromodulin 1 0.84 0.54 1.15
MMP-1 1 1.73 0.81 2.70
VEGF-A 1 1.84 0.75 2.31
MMP-3 1 2.43 0.27 2.32
PGE-synthase 1 5.25 1.14 3.23
HAS-2 1 2.50 0.31 1.59
IL-8 1 2.15 0.67 2.53
GROa 1 3.69 0.73 3.29
MCP-2 1 2.41 1.13 1.89
PAI-1 1 1.41 0.78 2.12
Downregulated genes
IGFBP-3 1 0.45 0.57 0.20
Tetranectin 1 0.60 1.61 0.43
WISP-2 1 0.66 1.19 0.71
aF, fibroblasts in inserts (control); K, keratinocytes in inserts. For gene
abbreviations, see figure legends.
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Cells Cells were isolated from samples of skin from young
individuals undergoing plastic reconstructive surgery at our
department. Approval from the local ethical committee was
obtained. 3 Epidermal keratinocytes were isolated from human
skin as described (Rheinwald, 1980). Briefly, skin samples were
treated with dispase, and epidermis was mechanically separated
from the underlying dermis, followed by mechanical fragmentation
and treatment of the separated epidermal sheets with trypsin.
Keratinocytes were propagated on irradiated 3T3 feeder cells in
DMEM:Ham’s F12 (4:1) supplemented with 5 mg per mL Zn-free
insulin (Sigma Chemical Co., St. Louis, MO), 2 nM 3,30,5-triiodo-D-
thyronine (Sigma), 0.4 mg per mL hydrocortisone (Sigma), 0.1 nM
cholera toxin (Sigma), 10 ng per mL epidermal growth factor
(Austral Biologicals, San Ramon, CA), 24 mg per mL adenine, 10%
fetal bovine serum (HyClone, Logan, UT), and 50 mg per mL
gentamicin. Keratinocytes at passage numbers 1 to 3 were used
for the experiments. Fibroblasts were isolated from the dermal
compartment by collagenase treatment, and subcultured in DMEM
supplemented with 10% bovine calf serum (HyClone) and 50 mg
per mL gentamicin. Subconfluent cells were washed with
phosphate-buffered saline and detached by treatment with trypsin.
Fibroblasts at passage numbers 3 to 7 were used for the
experiments.
Coculture A total of 0.35  106 fibroblasts were grown at the
bottom of plastic wells (six-well Falcon multiwell plates, surface
area 9.62 cm2 (BD Labware, Franklin Lakes, NJ)), and 0.2  106
keratinocytes were seeded in Falcon polyurethane cell culture
inserts (4.0 mm pore diameter). The inserts were pre-coated with a
mixture of 10 mg per mL bovine plasma fibronectin (Gibco BRL/Life
Technology, Paisley, UK), 30 mg per mL bovine collagen (Vitrogen,
Cohesion, Palo Alto, CA), and 10 mg per mL bovine serum albumin
(Sigma) for 2 h at 371C. As control, 0.15  106 fibroblasts were
grown in inserts instead of keratinocytes. Cell cultures were
prepared in separate compartments (wells and inserts) 1 d before
start of the cocultures. The culture medium during this period was
the standard growth medium for the two cell types as described
above. Upon initiation of the cocultures, the medium was changed
to DMEM:Ham’s F12 (4:1) supplemented with 0.5% fetal bovine
serum and the inserts were combined with the wells. Total volume
was 4 mL (2þ 2 mL). At this point keratinocyte density was around
50% and fibroblast density was near confluent. Coculture time was
continued for 48 h. At this time density was near confluent. In some
experiments neutralizing IL-1a antibodies (0.4 mg/mL) or IL-1
receptor antagonists (0.1 mg/mL) were added at start of cocultur-
ing. Neutralization dose (ND50) for the IL-1a antibodies was
approximately 0.002 mg per mL and the ED50 for the IL-1 receptor
antagonist was approximately 0.01 mg per mL according to the
manufacturer.
Affymetrix microarrays Total RNA was extracted from fibroblasts
using TRIzol reagent and quantified fluorometrically.
Preparation of labeled cRNA Probe preparation was performed as
recommended by the manufacturer of the microarrays (Affymetrix
Inc.). Poly(A) mRNA was isolated and used as a template for
double-stranded cDNA synthesis with an oligo(dT)24 primer
containing a T7 RNA polymerase promoter site added to the 30
Figure 2
Effect of IL-1 blocking strategies on expression of keratinocyte-
regulated genes. Fibroblasts were cocultured with keratinocytes in
presence or absence of 0.4 mg per mL neutralizing anti-IL-1a antibodies
or 0.1 mg per mL IL-1 receptor antagonists. After 48 h of mRNA
expression in fibroblasts was analyzed by northern blotting. F,
fibroblasts in inserts (control); K, keratinocytes in inserts; ab, anti-IL-
1a -antibodies; ra, IL-1 receptor antagonists; P4-H, prolyl-4-hydro-
xylase; LH-2, lysyl hydroxylase 2; MMP-1, matrix metalloproteinase 1;
VEGF-A, vascular endothelial growth factor A; MMP-3, matrix
metalloproteinase 3; PGE-synthase, prostaglandin E-synthase; HAS-
2, hyaluronan synthase 2; IL-8, interleukin-8; GROa, GRO1 oncogene;
MCP-2, monocyte chemotactic protein 2; PAI-1, plasminogen activator
inhibitor 1; IGFBP-3, insulin-like growth factor-binding protein 3; WISP-
2, WNT1-inducible signaling pathway protein 2.
Table IV. Relative mRNA signal levels by northern blottinga
F 48 h K 48 h IL-1 ab IL-1 ra
Cyclin B1 1 1.44 1.07 1.06
P4-H 1 1.83 1.25 1.40
LH-2 1 1.97 1.27 1.35
Fibromodulin 1 1.59 1.29 1.21
MMP-1 1 31.79 8.23 17.80
VEGF-A 1 2.15 1.18 0.91
MMP-3 1 1.45 0.61 0.67
PGE-synthase 1 2.05 0.80 0.98
HAS-2 1 2.04 1.22 2.28
IL-8 1 15.11 1.74 4.12
GROa 1 26.80 3.68 13.51
MCP-2 1 5.90 3.41 4.27
PAI-1 1 2.72 1.32 1.75
IGFBP-3 1 0.03 0.44 0.33
Tetranectin 1 0.04 0.50 0.33
WISP-2 1 0.30 0.93 0.74
aF, fibroblasts in inserts (control); K, keratinocytes in inserts. IL-1 ab, IL-
1 antibodies; IL-1 ra, IL-1 receptor antagonists. For gene abbreviations,
see figure legends.
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end. The cDNA was extracted with phenol-chloroform, ethanol-
precipitated, and used as a template for in vitro transcription with
biotin-labeled nucleotides. Labeled cRNA was fragmented and a
hybridization mix was generated as recommended.
Hybridization of microarrays Aliquots of each sample (10 mg of
cRNA in 200 mL of hybridization mix) were hybridized to a Gene-
chip Hu95A array. After hybridization, each array was washed,
stained with streptavidin phycoerythrin, washed again, hybridized
with biotin-labeled anti-streptavidin phycoerythrin antibodies,
restained with streptavidin phycoerythrin, and scanned.
Analysis of GENECHIP data Scanned output files were visually
inspected for hybridization artifacts. Arrays lacking significant
artifacts were analyzed by using Affymetrix GENECHIP 3.3 soft-
ware. Results are presented as ratios of intensities between test
(keratinocytes in inserts) samples and control (fibroblasts in inserts)
samples. Only twofold increases or decreases in hybridization
intensities were considered. Genes whose expression did not
exceed the background level in coculture with keratinocytes
(stimulated genes) or in control cultures (downregulated genes)
were omitted. For stimulated genes whose expression in the
control situation were equal to the background level or below,
quantification of the changes in expression level was not possible.
Likewise, for downregulated genes whose expression in cocultures
with keratinocytes was equal to background level or below,
quantification of the suppression was not possible. These
situations likely represent genes whose regulation is either turned
on or off. This is indicated in the tables (Tables I, II).
Northern blotting RNA was extracted from cells using TRIzol
reagent (Life Technology, Gaithersburg, MD). Total RNA was
quantified fluorometrically (SYBR Green II, FMC Bioproducts,
Rockland, ME). The RNA was denatured in formaldehyde,
separated by agarose gel electrophoresis, and transferred to nylon
membranes (Hybond Nþ , Amersham Biosciences AB, Uppsala,
Sweden). Fixation of RNA was performed by UV cross-linking (GS
GeneLinker, Bio-Rad, Hercules, CA), and membranes were
hybridized for 15 min at 651C in Rapid Hyb buffer (Amersham
Biosciences). Hybridization was performed with the following
cDNAs: fibromodulin (P. Roughley, McGill University, Canada),
GRO1 oncogene (GRO-a) (R. Gillitzer, University of Wurzburg,
Germany), WNT1-inducible signaling pathway protein 2 (WISP-2)
(D. Pennica, Genentech Inc., South San Francisco, CA), tetranectin
(U. Wewer, University of Copenhagen, Denmark), monocyte
chemotactic protein 2 (G. Opdenakker, University of Leuven,
Belgium), matrix metalloproteinase 1, 3 (MMP-1, -3) (V-M. Kahari
University of Turku, Finland), vascular endothelial growth factor A
(VEGF-A) (S. Wennstro¨m, University of Uppsala, Sweden), lysyl
hydroxylase 2 (C. Wang, University of Oulu, Finland), hyaluronan
synthase 2 (HAS-2) (E. Heldin, Uppsala University, Sweden), IL-8
(H. Prydz, University of Oslo, Norway), prostaglandin E-synthase
(PGE-synthase) (P-J. Jakobsson, Karolinska Institute, Sweden),
cyclin B1 (E. Prochownik, Children’s Hospital of Pittsburgh,
Pittsburgh, PA), prolyl 4-hydroxylase (T. Pihlajamieni, University of
Oulu, Finland), insulin-like growth factor binding protein 3 (IGFBP-
3) (S. Shimasaki, University of California, San Diego, CA), and
plasminogen activator inhibitor 1 (PAI-1) (J. Wojta, University of
Vienna, Austria). As control probe for RNA loading, oligonucleo-
tides coding for 18S ribosomal RNA (Barbu and Dautry, 1989) were
used. cDNAs were labeled with [a-32P]dCTP using the Rediprime II
kit (Amersham Biosciences), and the control oligonucleotides were
labeled with [g-32P]ATP and polynucleotide kinase (Barbu and
Dautry, 1989). cDNA probes were denatured and added to
prehybridization buffer, and hybridization proceeded for 2 h at
651C. Oligonucleotide probes were prehybridized and hybridized
at 371C. For cDNA probes, membranes were washed twice in
2  SSC/0.1% SDS at room temperature and then twice in
0.2  SSC/0.1% SDS at 651C. For oligonucleotide probes,
membranes were washed in 2  SSC/0.1% SDS at room
temperature followed by 0.2  SSC/0.1% SDS at 371C. Signals
were detected and quantified by autoradiography and densitome-
try (SigmaGel software, Jandel Scientific, Chicago, IL). Reprobing
with 18S probes was performed after removal of RNA from the
membranes by brief boiling in 0.1% SDS.
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